財經影音專區
精選全球財經影片,AI 自動生成摘要、雙語字幕學英文
🔥 精選推薦
美股焦點
📚 學英文
The Next Phase Of The Obesity Drug Race
五年後衛諾(Wegovy)獲 FDA 核准,醫療肥胖藥物市場進入高速發展期。諾和利(Novo Nordisk)與礼隆(Eli Lilly)本年推出 GLP-1 oral 藥片,Structure Therapeutics、Zealand Pharma 等新進者爭奪市佔。在美國糖尿病協會會議上,記者 Angelica Peebles 探討了市場竞争的加剧與未来创新方向。專家預言下一波創新將聚焦於更具成本效益的口服 GLP-1 類似物以及長效注射劑。CNBC 透過《The Next Phase Of The Obesity Drug Race》深入剖析產業鏈格局與投資機會。
#肥胖藥物
#GLP-1
CNBC Television
·
2026/06/13
CNBC Television
Big Challenges Ahead For Meta AI Chief Alexandr Wang After A Rocky First Year
#Meta AI#Alex Wang
Wall Street Journal
Why SpaceX’s $1.8T IPO Will Create New Millionaires in Texas | WSJ
#SpaceX#IPO
Wall Street Journal
Inside FIFA’s Race to Move Natural Grass to All 16 World Cup Stadiums | WSJ Tech Behind
#FIFA#世界杯
Inside Micron Taiwan’s Semiconductor Factory | Taiwan’s Mega Factories EP1
#半導體#晶片製造
CNBC Television
Bill Gates: AI is the biggest technical thing ever in my lifetime
#比爾蓋茲#人工智慧
AI Agents, Clearly Explained
#AI代理人#大型語言模型
What is the SPY ETF? (The #1 Traded ETF Explained)
#SPY#ETF
NVIDIA’s Jensen Huang on Securing American Leadership on AI
#NVIDIA#黃仁勳
英語學習單元
AI 轉錄、翻譯的雙語字幕教材